Matches in UGent Biblio for { <https://biblio.ugent.be/publication/1997728#aggregation> ?p ?o. }
Showing items 1 to 43 of
43
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B675312.
- aggregation creator B675313.
- aggregation creator B675314.
- aggregation creator B675315.
- aggregation creator B675316.
- aggregation creator B675317.
- aggregation creator B675318.
- aggregation creator B675319.
- aggregation creator B675320.
- aggregation creator B675321.
- aggregation creator B675322.
- aggregation creator B675323.
- aggregation creator person.
- aggregation date "2011".
- aggregation format "application/pdf".
- aggregation hasFormat 1997728.bibtex.
- aggregation hasFormat 1997728.csv.
- aggregation hasFormat 1997728.dc.
- aggregation hasFormat 1997728.didl.
- aggregation hasFormat 1997728.doc.
- aggregation hasFormat 1997728.json.
- aggregation hasFormat 1997728.mets.
- aggregation hasFormat 1997728.mods.
- aggregation hasFormat 1997728.rdf.
- aggregation hasFormat 1997728.ris.
- aggregation hasFormat 1997728.txt.
- aggregation hasFormat 1997728.xls.
- aggregation hasFormat 1997728.yaml.
- aggregation isPartOf urn:issn:0001-5644.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use ?".
- aggregation abstract "Polymorphisms in the region of the interleukin-28B (IL28B) gene have recently been associated with spontaneous and treatment induced clearance of hepatitis C virus infection. The specific mechanisms of how IL28B polymorphisms affect HCV suppression remain unknown. It is a matter of ongoing debate how to incorporate the IL28B data into the current treatment algorithms with pegylated interferon-alpha and ribavirin. The eventual role of the IL28B genotype in new therapeutic regimes with direct antiviral agents needs to be explored in the ongoing and future clinical studies with these agents.".
- aggregation authorList BK1037449.
- aggregation endPage "322".
- aggregation issue "2".
- aggregation startPage "317".
- aggregation volume "74".
- aggregation aggregates 1997749.
- aggregation isDescribedBy 1997728.
- aggregation similarTo LU-1997728.